increasing urbanisation of many developing countries may be expected to lead to a higher Background -A study was undertaken to assess whether the therapeutic aspects of prevalence of asthma in the future.
International consensus guidelines on asthma

Department of
Several doctors commented that they were aware that the treatment they offered was far from optimal but they were constrained by economic realities. Many complained that inter- Patient education was also seen as a problem. There was a reluctance to accept asthma as an 
Discussion
This survey shows that the treatment received by many asthmatic patients in developing countries falls far short of international guidelines. treated approximately 14 000 asthma cases annually.
There is a reliance on oral rather than inhaled therapy, and prophylactic medication is rarely Twenty five (61%) of the 41 doctors worked in rural locations and 16 (39%) in urban areas. prescribed. This is primarily because the required drugs are not available where the The median distance to the nearest teaching hospital was 180 km (range 2-1500 km), with patients live, or they are prohibitively expensive for long term use. a median journey time of six hours (range 10 minutes to one week). These figures excluded
There are advantages in a survey of expatriate doctors, although they may not be repthe two working in teaching hospitals and the doctor who commented "We are all there is, resentative of local medical practice. Most work primarily in voluntary capacities (rather than people will come 1000 miles to us".
in private practice treating a wealthy minority). Most were trained in the United Kingdom and have access to some journals including the BMJ  Electricity was available (at least part of the which published the British Thoracic Society asthma guidelines. 3 Differences in medical edutime) in 35 of the 41 centres. Oxygen was available in 23 places, and nebulisers in 19 cation or ignorance of modern asthma management are unlikely to have influenced the (15 electric, three foot pump, and one hand operated). Twenty six doctors had peak flow responses. We believe that our results probably represent close to the best care available to the meters, and only three had access to spirometric equipment. majority of patients with asthma. The response rate (25%) was relatively low. However, in some cases more than one questionnaire was sent to the same institution, some  The number of places where drugs were locally doctors were on home leave at the time of the survey, others may not treat asthma, and some available, and the frequency with which they were prescribed for asthma, are shown in table questionnaires may have been lost in the sometimes unreliable postal systems. The replies 2. In most cases where inhaled steroids were available the only dose was beclomethasone received represent the care available to approximately 14 000 asthmatic patients in 24 50 g. The two respondents working in teaching hospitals had prescribing patterns similar countries, which we believe is sufficient to enable valid conclusions to be drawn. to those in more remote situations because the cost of inhaled treatments, particularly steroids,
We have no information on treatment in "local" teaching hospitals. However, even if was too high for most patients.
they provide better treatment, this is of little relevance for those living in remote areas. For the patients of most respondents, travel to the  In 18 (44%) centres the patient had to pay the nearest teaching hospital would be impractical.
Our results suggest that little has changed in full cost of their drugs. Elsewhere, some subsidy (rarely above 25%) was provided by gov-the 20 years since problems of continuity of drug supply, cost, patient education in inhaler ernment or charity. The median (range) of average monthly local incomes (where given) use, and the hazards of oral steroids were regroup.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from ported in Nigeria. 4 There have been few other the disease is now largely untreated through strategies to bring care to people throughout studies of asthma treatment in developing the developing world". 9 This challenge remains countries. In Addis Ababa, Ethiopia, all today. The problem, as ever in the developing patients had previously tried traditional remworld, is the lack of resources, as neither govedies (without success) and the most common ernments nor patients can afford to pay for the treatment was oral combination bronchotreatment. The challenge should be addressed dilators. 5 A survey of general practitioners in to the pharmaceutical industry to make effectPunjab, India revealed overuse of ephedrine ive inhaled medication, particularly proand underuse of inhaled drugs, oxygen, and phylactic drugs, available at prices which are peak flow meters. 6 It was suggested that doctors realistically affordable. Until then, the comneeded better education. In our survey financial ment one doctor added to his reply will remain constraints were a greater obstacle to effective true: "The poor die, the rich live, matter of treatment than the doctors' knowledge.
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